Koroit Capital is a healthcare-focused, research-intensive, and event-driven investor in long, and occasionally short, investments in the public and private markets. Utilizing a proprietary focus of seeking out clinical stage biotechnology companies that are actively working to address currently unmet medical needs for life threatening conditions allows the fund to unlock deep value through cutting-edge and potentially life-changing therapies. The fund’s objective is to identify groundbreaking drugs and medical devices that have the potential to serve as, first-in-class and best-in-class, treatments for their respective indications.
A secondary objective of the fund involves the exploitation of short-term market volatility to create attractive entry and exit points. Through the early identification of volatility trends, the fund is able to remain nimble in its investments and highly responsive to market changes, utilizing long and short techniques to facilitate the achievement of maximum gains while simultaneously mitigating losses. The diligent practice of hedging allows Koroit Capital to invest unwaveringly in the healthcare space while also embedding a layer of protection underlying all of its investments.
Koroit Capital 